Ultrasound of Salivary Glands in Sjögren's Syndrome and the OMERACT Semi-Quantitative Scale: What Is Confirmed by the Source — МЕДТРЕЙН Asia
General ultrasound diagnostics

Ultrasound of Salivary Glands in Sjögren's Syndrome and the OMERACT Semi-Quantitative Scale: What Is Confirmed by the Source

Briefly. In the provided source fragments, there are no data on the OMERACT semi-quantitative scale specifically for ultrasound of salivary glands in Sjögren's syndrome (grades, thresholds, criteria). OMERACT (Outcome Measures in Rheumatology) is described as an international initiative for standardizing outcome measures in rheumatology; specific salivary gland semiotics are absent from the source. [verify]

What Is Known About OMERACT From the Available Source

According to the provided fragments, OMERACT (Outcome Measures in Rheumatology) is an international initiative for standardizing outcome measures in rheumatology. In the context of the source, the OMERACT approach is applied primarily in research tasks and in structured dynamic monitoring rather than as a mandatory element of routine reporting.

Data on Salivary Glands

In the provided fragments, there is no description of the OMERACT semi-quantitative scale for ultrasound of salivary glands in Sjögren's syndrome: there are no grades, threshold values, definitions of echo-structural changes (hypoechoic/anechoic areas, parenchymal heterogeneity), or reproducibility data for this location. [verify]

Sjögren's Syndrome in the Source

In the bibliographic fragments of EFSUMB guidelines, a study on subclinical joint involvement in primary Sjögren's syndrome assessed by ultrasonography is mentioned (Fujimura T. et al., Mod Rheumatol 2015); however, this concerns joint manifestations rather than salivary gland semiotics. The source does not provide methodological OMERACT criteria for salivary glands. [verify]

General Information on OMERACT Grades in the Source

The only specific OMERACT semi-quantitative grade provided in the fragments relates to osteophytes (within OMERACT-OARSI for osteoarthritis):

ScoreDescription
0none
1small (equivocal, "irregularity" of bone contour)
2moderate (distinct but small)
3large (marked)

This scale is provided in the source to illustrate the principle of OMERACT semi-quantitative assessment and does not apply to salivary glands. The source also indicates that in routine clinical practice in the Russian Federation, the use of OMERACT grades in the report is not a mandatory standard and is applied primarily in scientific research, clinical trials, and structured dynamic monitoring.

Conclusion

For a correct description of the OMERACT semi-quantitative scale for ultrasound of salivary glands in Sjögren's syndrome (specifying grades and criteria), a primary source containing the corresponding consensus is required; it is absent from the provided fragments. [verify]

Frequently asked questions

Is there a ready-made OMERACT scale for ultrasound of salivary glands in Sjögren's syndrome in the source?

No. In the provided fragments, OMERACT grades, thresholds, and criteria specifically for salivary glands are absent. [verify]

What is OMERACT according to the source data?

OMERACT (Outcome Measures in Rheumatology) is an international initiative for standardizing outcome measures in rheumatology, applied primarily in research contexts and in dynamic monitoring.

What is the only specific OMERACT grade provided in the fragments?

The OMERACT semi-quantitative scale for osteophytes (OMERACT-OARSI): 0 — none, 1 — small, 2 — moderate, 3 — large. It does not apply to salivary glands.

Is OMERACT grading mandatory in routine reporting?

According to the source, in routine practice in the Russian Federation this is not a standard and not a mandatory requirement; it is applied primarily in research and structured dynamic monitoring.

Is Sjögren's syndrome mentioned in the source?

Yes, but in the context of subclinical joint involvement (Fujimura T. et al., 2015), not in salivary gland semiotics.

The material is intended for specialists and does not replace clinical judgment. Threshold values are periodically reviewed — refer to the current edition of the applicable consensus.
Sources: Verified answers from the Medtrain Expert Panel, 2026; The EFSUMB Guidelines and Recommendations for Musculoskeletal Ultrasound – Part II (Naredo et al., 2022); The EFSUMB Guidelines and Recommendations for Musculoskeletal Ultrasound – Part I (Fodor et al., 2022); Fundamentals of Musculoskeletal Ultrasound, 4th ed. (Jon A. Jacobson, 2026).
View specialty courses: General Ultrasound →
Спросить Alex Отвечу на любой вопрос · 24/7 · на любом языке